NASDAQ:PTGX
Protagonist Therapeutics, Inc.
- Stock
Last Close
31.94
17/05 20:00
Market Cap
1.44B
Beta: 1.95
Volume Today
437.12K
Avg: 1.73M
PE Ratio
−11.44
PFCF: −12.63
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -11.07M - | -14.86M 34.19% | -37.18M 150.22% | -36.96M 0.59% | -38.92M 5.32% | -77.19M 98.30% | -66.15M 14.30% | -125.55M 89.80% | -127.39M 1.47% | -78.95M 38.02% | |
depreciation and amortization | 258K - | 247K 4.26% | 317K 28.34% | 406K 28.08% | 527K 29.80% | 2.50M 373.43% | 2.56M 2.77% | 2.77M 8.23% | 3.37M 21.41% | 3.31M 1.69% | |
deferred income tax | -8K - | 151K 1,987.50% | -658K - | -775K 17.78% | 1.44M 285.55% | 2.87M - | |||||
stock based compensation | 42K - | 99K 135.71% | 2.13M 2,051.52% | 4.24M 99.11% | 6.92M 63.15% | 8.35M 20.73% | 7.90M 5.44% | 16.39M 107.56% | 24.20M 47.62% | 29.29M 21.04% | |
change in working capital | 1.26M - | 52K 95.87% | -112K 315.38% | 35.56M 31,847.32% | -18.02M 150.67% | 26.14M 245.11% | -19.02M 172.74% | -3.31M 82.57% | -7.77M 134.34% | -19.51M 151.24% | |
accounts receivables | -1.82M - | -2.77M 52.59% | -757K 72.68% | 3.34M 541.08% | -915K 127.40% | 4.24M 563.61% | -9.99M 335.50% | ||||
inventory | 5.53M - | 3.85M 30.33% | 757K 80.35% | -3.34M 541.08% | 915K 127.40% | -4.24M 563.61% | -9.52M 124.45% | ||||
accounts payables | 179K - | 898K 401.68% | -115K 112.81% | 91K 179.13% | 4.43M 4,768.13% | -3M 167.72% | 309K 110.30% | -1.39M 549.84% | 2.04M 247.12% | -2.87M 240.24% | |
other working capital | 1.08M - | -846K 178.26% | 3K 100.35% | 31.75M 1,058,300% | -23.53M 174.10% | 29.14M 223.86% | -19.32M 166.31% | -1.92M 90.04% | -9.81M 409.93% | 2.87M 129.23% | |
other non cash items | 1.77M - | 83K 95.31% | 4.72M 5,585.54% | 625K 86.76% | 206K 67.04% | -557K 370.39% | 781K 240.22% | 1.83M 134.31% | -549K 130% | -7.24M 1,219.31% | |
net cash provided by operating activities | -7.74M - | -14.38M 85.78% | -29.97M 108.36% | 3.87M 112.92% | -49.95M 1,389.95% | -41.53M 16.86% | -72.48M 74.55% | -107.86M 48.81% | -108.14M 0.25% | -70.24M 35.05% | |
investments in property plant and equipment | -299K - | -399K 33.44% | -379K 5.01% | -666K 75.73% | -486K 27.03% | -967K 98.97% | -471K 51.29% | -1.10M 133.76% | -795K 27.79% | -609K 23.40% | |
acquisitions net | 52.74M - | 90.49M 71.58% | 14.76M 83.69% | -91.47M 719.74% | |||||||
purchases of investments | -7.87M - | -73.17M 830.31% | -39.55M 45.95% | -71.06M 79.69% | -166.94M 134.92% | -280.03M 67.75% | -286.59M 2.34% | -214.87M 25.02% | -191.04M 11.09% | ||
sales maturities of investments | 14.19M - | 56.03M 294.95% | 73.76M 31.63% | 114.19M 54.82% | 189.53M 65.98% | 271.83M 43.42% | 307.14M 12.99% | 152.40M 50.38% | |||
other investing activites | 32K - | -52.74M - | -90.49M 71.58% | -14.76M 83.69% | 91.47M 719.74% | ||||||
net cash used for investing activites | -299K - | -8.26M 2,663.88% | -59.33M 617.91% | 15.82M 126.67% | 2.21M 86.01% | -53.71M 2,527.02% | -90.97M 69.36% | -15.86M 82.56% | 91.47M 676.72% | -39.26M 142.92% | |
debt repayment | -9.77M - | -10.52M 7.77% | |||||||||
common stock issued | 83.65M - | 64.55M 22.83% | 23.18M 64.09% | 34.49M 48.79% | 255.37M 640.36% | 123.83M 51.51% | 14.55M 88.25% | 132.10M 807.72% | |||
common stock repurchased | -189K - | -188K 0.53% | |||||||||
dividends paid | |||||||||||
other financing activites | 9.00M - | 17.42M 93.48% | 22.66M 30.08% | 1.01M 95.56% | 934K 7.25% | 21.31M 2,181.48% | 2.79M 86.93% | 6.28M 125.60% | 4.47M 28.81% | 38.38M 757.97% | |
net cash used provided by financing activities | 9.00M - | 17.42M 93.48% | 106.31M 510.29% | 65.55M 38.34% | 24.11M 63.21% | 46.04M 90.90% | 247.63M 437.90% | 129.92M 47.53% | 18.84M 85.50% | 170.48M 804.96% | |
effect of forex changes on cash | -97K - | -39K 59.79% | 22K 156.41% | 146K 563.64% | -177K 221.23% | -26K 85.31% | 175K 773.08% | -126K 172% | -90K 28.57% | ||
net change in cash | 864K - | -5.27M 709.84% | 17.03M 423.19% | 85.39M 401.47% | -23.80M 127.87% | -49.23M 106.87% | 84.35M 271.35% | 6.07M 92.80% | 2.08M 65.76% | 60.98M 2,833.29% | |
cash at beginning of period | 8.46M - | 9.32M 10.21% | 4.05M 56.51% | 21.09M 420.20% | 106.49M 404.83% | 82.69M 22.35% | 33.47M 59.53% | 117.82M 252.05% | 123.89M 5.15% | 125.97M 1.68% | |
cash at end of period | 9.32M - | 4.05M 56.51% | 21.08M 419.95% | 106.49M 405.07% | 82.69M 22.35% | 33.47M 59.53% | 117.82M 252.05% | 123.89M 5.15% | 125.97M 1.68% | 186.95M 48.41% | |
operating cash flow | -7.74M - | -14.38M 85.78% | -29.97M 108.36% | 3.87M 112.92% | -49.95M 1,389.95% | -41.53M 16.86% | -72.48M 74.55% | -107.86M 48.81% | -108.14M 0.25% | -70.24M 35.05% | |
capital expenditure | -299K - | -399K 33.44% | -379K 5.01% | -666K 75.73% | -486K 27.03% | -967K 98.97% | -471K 51.29% | -1.10M 133.76% | -795K 27.79% | -609K 23.40% | |
free cash flow | -8.04M - | -14.78M 83.83% | -30.35M 105.30% | 3.21M 110.56% | -50.43M 1,673.08% | -42.49M 15.74% | -72.95M 71.68% | -108.97M 49.36% | -108.93M 0.03% | -70.84M 34.96% |
All numbers in USD (except ratios and percentages)